Business Insider

Umoja Biopharma Announces Oversubscribed $100 Million Series C Financing to Advance In Vivo CAR T Pipeline through Key Oncology Clinical Milestones

Series C financing co-led by Double Point Ventures and DCVC Bio Proceeds to support the clinical development of VivoVec™ derived in vivo CAR T cells SEATTLE, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Umoja ...
Business Wire

Ozette Technologies Announces New Collaboration with Umoja Biopharma to Accelerate Biomarker Discovery in Preclinical Studies

SEATTLE--(BUSINESS WIRE)--Ozette Technologies, Inc., a technology-driven life sciences company, today announced its collaboration with Umoja Biopharma, Inc., a transformative immuno-oncology company ...
Business Insider

Umoja Biopharma Appoints Scott Myers as Chairman of its Board of Directors

SEATTLE, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc. (Umoja), the clinical-stage leader of in vivo and off-the-shelf therapies that aim to realize the full reach and promise of CAR T-cells ...